Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 175,000 | reported | 15 Feb 2024 | tx 2+475,000 |
| Aldeyra Therapeutics, Inc. | 17,878 | reported | 06 Sept 2019 | tx 7+627,566 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Feb 2024 | GRANT_AWARD | Trevi Therapeutics, Inc. | 175,000 | 0.00 USD | deriv |
| 14 Nov 2022 | GRANT_AWARD | Trevi Therapeutics, Inc. | 300,000 | 0.00 USD | deriv |
| 06 Sept 2019 | PURCHASE | Aldeyra Therapeutics, Inc. | 5,000 | 5.06 USD | |
| 05 Mar 2019 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 3,503 | 0.00 USD | |
| 05 Mar 2019 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 250,000 | 0.00 USD | deriv |
| 29 Dec 2017 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 4,774 | 4.00 USD | |
| 06 Mar 2018 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 108,633 | 0.00 USD | deriv |
| 03 Mar 2017 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 155,656 | 0.00 USD | deriv |
| 11 Jan 2016 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |